BiotechTube
Home/Molecular Partners/Philippe Legenne, M.D.
PL

Philippe Legenne, M.D.

Chief Medical Officer

Molecular Partners

Therapeutic Areas

Oncology

Molecular Partners Pipeline

DrugIndicationPhase
MP0533Acute Myeloid Leukemia (AML)Phase 1/2a
MP0317Solid TumorsPhase 1
MP0712Small Cell Lung Cancer & Neuroendocrine CancersPreclinical
Switch-DARPin PlatformVarious Oncology TargetsDiscovery/Preclinical
Radio-DARPin PlatformVarious Oncology TargetsDiscovery/Preclinical

Leadership Team at Molecular Partners

PA
Patrick Amstutz, Ph.D.
Chief Executive Officer
AZ
Alexander Zürcher
Chief Operating Officer
MS
Martin Steegmaier, Ph.D.
Chief Scientific Officer
MT
Michael Tobias Stumpp, Ph.D.
EVP Projects
RG
Renate Gloggner
EVP People and Community
MP
Michael Pitzner
EVP General Counsel and Partnering
SL
Seth Lewis
EVP Corporate Finance
RH
Robert Hendriks
SVP Finance
DS
Daniel Steiner, Ph.D.
SVP Research & Technology
LJ
Laura Jeanbart, Ph.D.
Head of Portfolio Management and Corporate Communications
View full Molecular Partners profile